Glipizide
💊 Glipizide is a short-acting sulphonylurea used in the management of Type 2 Diabetes Mellitus (T2DM).
⚠️ It can cause hypoglycaemia (especially if meals are missed), but the risk is lower than with long-acting agents like glibenclamide.
👉 Always check the BNF for the latest details.
⚙️ Mode of Action
- Stimulates pancreatic β-cell receptors → insulin release 🍬.
- Suppresses hepatic gluconeogenesis 🛑, reducing glucose output from the liver.
- Overall: lowers blood glucose by ↑ insulin and ↓ hepatic glucose production.
📌 Indications
- Type 2 Diabetes Mellitus (T2DM) – when lifestyle ± metformin are inadequate.
💊 Dose
- 2.5–5 mg with food (usual max: 20 mg/day).
- Take with meals to reduce risk of hypos.
🔗 Interactions
- ⬆️ Risk of hypoglycaemia with:
- Chloramphenicol
- Sulphonamides, Co-trimoxazole
- Warfarin
- Fibrates
- Alcohol 🍷 can potentiate hypo risk.
⚠️ Cautions
- 💡 Use with caution in elderly or those with renal/hepatic impairment → ↑ hypo risk.
- Obesity: metformin usually preferred first-line.
- Acute illness/surgery: consider switching to VRIII (Variable Rate IV Insulin Infusion).
⛔ Contraindications
- Type 1 Diabetes Mellitus.
- Diabetic ketoacidosis.
- See BNF for full list.
💥 Side Effects
- 🍬 Hypoglycaemia (classic exam pearl).
- ⚖️ Weight gain.
- 😣 GI upset (nausea, diarrhoea).
- 🌸 Rash or hypersensitivity reactions.
- 🩸 Rare: blood dyscrasias (agranulocytosis, haemolytic anaemia).
- Hepatic toxicity (rare but important).
🧠 Clinical Pearls
- Safer than glibenclamide in the elderly due to its shorter duration of action.
- Still carries hypo risk – always counsel on "hypo rules" (carry glucose, don’t skip meals, recognise warning signs).
- Useful when patients cannot tolerate metformin or need additional control before insulin is started.
📚 References